“…General and j-receptor-selective opioid antagonists were reported to be beneficial in experimental models of spinal cord injury and TBI, suggesting that endogenous dynorphins contribute to secondary CNS injury (Behrmann et al, 1993;Faden et al, 1987;McIntosh et al, 1987;Vink et al, 1990). Furthermore, Dyn A, the most pathogenic dynorphin, may cause tissue injury and cell death, and may exacerbate the clinical severity of traumatic injury to the head or spinal cord (Faden, 1990(Faden, ,1996Goody et al, 2003;Hauser et al, 2005;Headrick et al, 1995;Hu et al, 1996;McIntosh et al, 1994;Woods et al, 2006). Dyn A-induced tissue injury may involve both opioid and non-opioid components (Adjan et al, 2007;Bakshi et al, 1992;Faden, 1990;Hauser et al, 2005;Long et al, 1994;Woods et al, 2006).…”